165 related articles for article (PubMed ID: 34421639)
21. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
[TBL] [Abstract][Full Text] [Related]
22. Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma.
Tombolan L; Millino C; Pacchioni B; Cattelan M; Zin A; Bonvini P; Bisogno G
Front Genet; 2020; 11():606274. PubMed ID: 33362864
[TBL] [Abstract][Full Text] [Related]
23. FAK Signaling in Rhabdomyosarcoma.
Perrone C; Pomella S; Cassandri M; Braghini MR; Pezzella M; Locatelli F; Rota R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182556
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma.
Al-Tahan A; Sarkis O; Harajly M; Baghdadi OK; Zibara K; Boulos F; Dighe D; Kregel S; Bazarbachi A; El-Sabban M; Skapek SX; Saab R
Pediatr Blood Cancer; 2012 Jun; 58(6):877-84. PubMed ID: 21755593
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA.
Tombolan L; Zampini M; Casara S; Boldrin E; Zin A; Bisogno G; Rosolen A; De Pittà C; Lanfranchi G
PLoS One; 2015; 10(4):e0125171. PubMed ID: 25915942
[TBL] [Abstract][Full Text] [Related]
26. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
[TBL] [Abstract][Full Text] [Related]
27. Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model.
Dobson CC; Naing T; Beug ST; Faye MD; Chabot J; St-Jean M; Walker DE; LaCasse EC; Stojdl DF; Korneluk RG; Holcik M
Oncotarget; 2017 Jan; 8(2):3495-3508. PubMed ID: 27966453
[TBL] [Abstract][Full Text] [Related]
28. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
[TBL] [Abstract][Full Text] [Related]
29. Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts.
Ghayad SE; Rammal G; Ghamloush F; Basma H; Nasr R; Diab-Assaf M; Chelala C; Saab R
Sci Rep; 2016 Nov; 6():37088. PubMed ID: 27853183
[TBL] [Abstract][Full Text] [Related]
30. Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma.
Pomella S; Danielli SG; Alaggio R; Breunis WB; Hamed E; Selfe J; Wachtel M; Walters ZS; Schäfer BW; Rota R; Shipley JM; Hettmer S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345159
[TBL] [Abstract][Full Text] [Related]
31. KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma.
Sobral LM; Sechler M; Parrish JK; McCann TS; Jones KL; Black JC; Jedlicka P
Genes Cancer; 2020; 11(1-2):53-65. PubMed ID: 32577157
[TBL] [Abstract][Full Text] [Related]
32. Signaling pathways in Rhabdomyosarcoma invasion and metastasis.
Ramadan F; Fahs A; Ghayad SE; Saab R
Cancer Metastasis Rev; 2020 Mar; 39(1):287-301. PubMed ID: 31989508
[TBL] [Abstract][Full Text] [Related]
33. Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.
Slemmons KK; Crose LE; Rudzinski E; Bentley RC; Linardic CM
PLoS One; 2015; 10(10):e0140781. PubMed ID: 26496700
[TBL] [Abstract][Full Text] [Related]
34. Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members.
Megiorni F; Cialfi S; McDowell HP; Felsani A; Camero S; Guffanti A; Pizer B; Clerico A; De Grazia A; Pizzuti A; Moles A; Dominici C
BMC Cancer; 2014 Nov; 14():880. PubMed ID: 25427715
[TBL] [Abstract][Full Text] [Related]
35. Role of microRNAs in skeletal muscle development and rhabdomyosarcoma (review).
Ju H; Yang Y; Sheng A; Jiang X
Mol Med Rep; 2015 Jun; 11(6):4019-24. PubMed ID: 25633282
[TBL] [Abstract][Full Text] [Related]
36. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma.
Miyachi M; Tsuchiya K; Yoshida H; Yagyu S; Kikuchi K; Misawa A; Iehara T; Hosoi H
Biochem Biophys Res Commun; 2010 Sep; 400(1):89-93. PubMed ID: 20696132
[TBL] [Abstract][Full Text] [Related]
37. Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma.
McKinnon T; Venier R; Yohe M; Sindiri S; Gryder BE; Shern JF; Kabaroff L; Dickson B; Schleicher K; Chouinard-Pelletier G; Menezes S; Gupta A; Zhang X; Guha R; Ferrer M; Thomas CJ; Wei Y; Davani D; Guidos CJ; Khan J; Gladdy RA
Oncogene; 2018 May; 37(20):2630-2644. PubMed ID: 29487419
[TBL] [Abstract][Full Text] [Related]
38. Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries.
Schaaf GJ; Ruijter JM; van Ruissen F; Zwijnenburg DA; Waaijer R; Valentijn LJ; Benit-Deekman J; van Kampen AH; Baas F; Kool M
FASEB J; 2005 Mar; 19(3):404-6. PubMed ID: 15629888
[TBL] [Abstract][Full Text] [Related]
39. Update on molecular findings in rhabdomyosarcoma.
El Demellawy D; McGowan-Jordan J; de Nanassy J; Chernetsova E; Nasr A
Pathology; 2017 Apr; 49(3):238-246. PubMed ID: 28256213
[TBL] [Abstract][Full Text] [Related]
40. Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas.
Boscolo Sesillo F; Sacco A
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]